US Patent 11857608 Dosage forms of tissue kallikrein 1
Patent 11857608 was granted and assigned to DiaMedica on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+21 properties)
Article (+356 characters)
US Patent 11857608 Dosage forms of tissue kallikrein 1
Article
Patent abstract
Provided are dosage forms of one or more tissue kallikrein-1 (KLK1) polypeptides which have a total KLK1 polypeptide dosage of about 0.1 μg/kg to about 10.0 μg/kg, including subcutaneous and intravenous dosage forms. Also provided are related devices and methods of use thereof, for example, for treating ischemic and hemorrhagic conditions.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Rick Pauls0
Todd Verdoorn0
Date of Patent
January 2, 2024
0Patent Application Number
164920590
Date Filed
March 9, 2018
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11857608 Dosage forms of tissue kallikrein 1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
